Abstract:
One of the most important public health challenges of the 21st century is the search of new preventive or therapeutic anti-infective strategies, based on a combination of the plant-derived quorum-sensing inhibitors (QSI) with anti-inflammatory agents, and immunomodulators without pressure on the selection factors and the effect of dysbiosis [1]. Among the family Brassicaceae crucial secondary metabolites are isothiocyanates, such as sulforaphane (SFN), erucine etc. which have anticancer, anti-atherogenic, hepatoprotective, antimutagenic, antioxidant, antifungal, antibacterial, and bioherbicidal activities [2, 3].